Clinical Trial Update: Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update assessing safety and efficacy of melatonin in patients with multiple sclerosis, including primary progressive multiple sclerosis, across P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Sclerosis, Multiple, Autoimmune Diseases of the Nervous System | Phase 1, Phase 2 | Status: TERMINATED